LANCASTER GENERAL HOSPITAL — History
CCN 390100 | 3-year financial timeline | COVID resilience: 47/100
🛡️ Public data only — no PHI permitted on this instance.
$1.3B
Latest Revenue (FY2022)
+4.6%
Revenue CAGR (3yr)
-2.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $1.2B | $1.3B | $1.3B | +4.3% | +4.6% |
| Operating Expenses | $1.2B | $1.3B | $1.4B | +5.8% | +7.3% |
| Operating Margin | 2.6% | -1.1% | -2.6% | -124.0% | +0.0% |
| Net Income | $32M | $-15M | $-34M | -133.7% | +0.0% |
| Licensed Beds | 620 | 620 | 620 | +0.0% | +0.0% |
| Total Patient Days | 150,780 | 160,916 | 150,655 | -6.4% | -0.0% |
| Medicare Day % | 28% | 26% | 26% | +0.1% | -2.8% |
| Medicaid Day % | 3% | 2% | 3% | +36.9% | +7.7% |
COVID Impact & Recovery
Resilience Score: 47/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +9.4% ($1.2B → $1.3B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.6%
This Hospital
+7.6%
State Avg
Latest Margin
-2.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.4B | -5.1% |
| FY2024 (proj) | $1.4B | -7.7% |
| FY2025 (proj) | $1.5B | -10.3% |